Dual randomization in cardiovascular trials
Is the emperor really wearing new clothes? Informed consent for acute coronary syndromes
Clinical evaluation of chelation therapy: Is there any wheat amidst the chaff?
Atorvastatin Versus Revascularization Treatment (AVERT): Fact or fancy?
Should we revise our diagnostic methods for Q-wave myocardial infarction in the presence of right bundle branch block?
Classification and pharmacology of antiarrhythmic drugs
Chronic heart failure and exercise
Hierarchy of risk based on history and location of prior myocardial infarction in the thrombolytic era
Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure
Arrhythmia risk stratification in idiopathic dilated cardiomyopathy based on echocardiography and 12-lead, signal-averaged, and 24-hour Holter electrocardiography
Exercise-induced ST-segment depression and systolic dysfunction in patients with nonobstructive hypertrophic cardiomyopathy
Infarct size determination by technetium 99m sestamibi single-photon emission computed tomography predicts survival in patients with chronic coronary artery disease
Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin
Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade
First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: Results of the TIMI 15A and 15B trials
Is informed consent to clinical trials an “upside selective” process in acute coronary syndromes?
Association of age, sex, and race with body iron stores in adults: Analysis of NHANES III data
Association between depression and worse disease-specific functional status in outpatients with coronary artery disease
Heart diseases affecting the liver and liver diseases affecting the heart
Collateral recruitment and “warm-up” after first exercise in ischemic heart disease
Prodromal unstable angina in acute myocardial infarction: Prognostic value of short- and long-term outcome and predictor of infarct size
Histopathologic and clinical characterization of cardiac myxoma: Review of 53 cases from a single institution
Chelation therapy for coronary heart disease: An overview of all clinical investigations
Observations on the transition from intermittent to permanent atrial fibrillation
A novel mutation in KVLQT1, L122P, found in a family with autosomal dominant long QT syndrome
Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study
Effect of exercise training on heart rate variability in patients with new-onset left ventricular dysfunction after myocardial infarction
Race, baseline characteristics, and clinical outcomes after coronary intervention: The New Approaches in Coronary Interventions (NACI) registry
A1166C polymorphism of the angiotensin II type 1 receptor gene and risk of adverse events after coronary catheter interventions
Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery
Highlights from the American College of Cardiology 49th Annual Scientific Sessions: March 12 to 15, 2000
Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin
Memory function in patients with stable, moderate to severe cardiac failure
Improvement of exercise capacity and left ventricular diastolic function with metoprolol XL after acute myocardial infarction